IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291,365 | -71.9% | 30,256 | -69.3% | 0.00% | -100.0% |
| Q1 2023 | $1,035,641 | -75.9% | 98,445 | -71.6% | 0.00% | -71.4% |
| Q4 2022 | $4,289,530 | -17.4% | 346,209 | -31.0% | 0.01% | -22.2% |
| Q3 2022 | $5,196,000 | +1673.4% | 501,577 | +1876.6% | 0.01% | – |
| Q2 2022 | $293,000 | -35.0% | 25,376 | -27.5% | 0.00% | -100.0% |
| Q1 2022 | $451,000 | -65.8% | 34,994 | -69.1% | 0.00% | -50.0% |
| Q4 2021 | $1,320,000 | -45.1% | 113,234 | -38.5% | 0.00% | -50.0% |
| Q3 2021 | $2,404,000 | +1.5% | 184,074 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $2,369,000 | +116.1% | 184,074 | +87.7% | 0.00% | +200.0% |
| Q1 2021 | $1,096,000 | -56.8% | 98,045 | -56.0% | 0.00% | -50.0% |
| Q4 2020 | $2,536,000 | +152.8% | 222,666 | +106.5% | 0.00% | 0.0% |
| Q3 2020 | $1,003,000 | – | 107,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |